DarioHealth Corp.DRIO

DarioHealth developed DarioSHIFT initiative using AI agents to improve efficiency of sales, services, development and RFP functions.

“In addition, we have developed DarioSHIFT, an operations initiative focused on using AI agents and tools and agentic AI capabilities to improve the efficiency and scalability of our business operations. DarioSHIFT is intended to support functions such as sales development, member services, software development and responses to requests for proposals by automating routine tasks, optimizing workflows and accelerating certain development activities.”

DarioHealth has deployed AI agents and tools in sales, member services, developer tools and RFP support with positive impacts.

“DarioSHIFT has already successfully deployed several AI tools and is currently expanding deployment of AI agents across multiple use cases, including sales development representative optimization, member services optimization, developer tools and RFP response support. Early use cases have shown a positive impact on how AI agents take on repeatable, process-driven activities so that our teams can focus on higher value and more complex work. These early-stage learnings are intended to inform how we may redesign workflows, staffing models and support technology over time. In addition, we already have several agents in regular use with demonstrative impacts, particularly within software development workflows, such as an AI-enabled scrum master agent that evaluates user stories against defined quality criteria and surfaces recommendations automatically, which we believe will contribute to increased developer velocity and more efficient use of resources over time.”

DarioHealth plans to continue maturing DarioSHIFT with AI agent usage and monitor effects on costs and revenue.

“Looking ahead to 2026, we plan to continue the rollout of DarioIQ through a phased, risk-managed roadmap. We expect to broaden availability within our D2C offerings, explore additional condition areas, and initiate targeted deployments with select employer and health plan customers, subject to ongoing evaluation of safety, performance, and customer needs. In parallel, we intend to refine DarioIQ’s capabilities, safeguards, and integration points across our platform as we gather additional operational experience, clinical and engagement data, and stakeholder feedback. We will also continue to mature DarioSHIFT with the meaningful usage and deployment of AI agents and tools and monitor the impact on operational costs and revenue ratios.”